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Abstract:
Background: Diabetes is a foreign disease today. This is a chronic, metabolic disease that is
characterized by elevated blood glucose levels. There are many types of disease. Each of them
has different characteristics. The key in the fight against the disease is to perform appropriate
laboratory tests to diagnose diabetes and to introduce appropriate treatment to prevent many
complications, e.g. impairment of: vision, kidneys, cardiovascular system or hearing.
Material and methods:  A proper review of the literature was used, which identifies risk
factors, complications and proper management in diagnosing diabetes.
Results: The growing problem of diabetes forces us to find the most accurate way to treat the
disease.  Performing  reliable  diagnostics  is  crucial.  The  reference  method  (IDMS)  and
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methods  used  in  routine  diagnostics,  oxidase  hexokinase  are  the  basic  and  necessary
laboratory tests used in the diagnosis of diabetes.
Conclusions:  In  the  coming  years,  the  number  of  patients  suffering  from  diabetes  will
continue to grow. Diagnosis and treatment of this disease is extremely important,  because
neglecting the disease can have many serious consequences for healthy physical and mental
functioning. The basis is the performance of correct tests, which allows for proper treatment.
Key words:  diabetes, hyperglycaemia,  atherosclerosis,  cardiovascular,  sight complications,
hearing complications, kidney complications
Introduction
        Diabetes is a chronic metabolic disease characterized by elevated blood glucose levels
- above 7.0 mmol / l. It is also referred to as a metabolic syndrome, which is associated with
abnormal carbohydrate metabolizm (primary diabetes). To diagnose diabetes, the ADA and
WHO criteria  are  used,  which  include  the  finding  of  elevated  fasting  blood glucose  and
glucose load testing. The number of people with diabetes around the world is around 170
million  people,  and  the  incidence  is  still  increasing.  Forecasts  suggest  that  by  2030,  the
number of people with diabetes will amount to 360 million [1, 2, 3].
Diabetes is an important clinical problem in older people - affects up to 25-30% of
seniors.  The  body's  aging  itself  is  associated  with  specific  disorders  of  carbohydrate
metabolism,  and risk factors  such as reduced physical  activity,  obesity,  decreased  muscle
mass, changes in diet, use of drugs, co-existing diseases or genetic predisposition favor the
occurrence of diabetes [2, 4, 5].
Depending on the pathomechanism, type 1 diabetes mellitus and type 2 diabetes are
distinguished.  Type 1  diabetes  is  caused by the  disorder  or  destruction  of  the  β-islets  of
Langerhans pancreas, which are responsible for the production and secretion of insulin. It
develops  rapidly,  manifests  itself  in  increased  thirst,  frequent  urination,  weight  loss,  and
general feeling of fatigue and weakness. Lack of treatment may lead to exhaustion of the
body's compensation and even death. It is most common in young people and children, and
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the incidence in comparison with type 2 diabetes is 5-10%. The basic treatment method is
insulin substitution and proper nutrition or moderate physical exercise [2].
Type 2 diabetes is caused by abnormal secretion and / or action of insulin in the body
(reduced  sensitivity  of  tissues  to  insulin).  It  is  characterized  by  gradual  and  secretive
development. In the early phase of the disease, patients are accompanied by polyphagia. As a
result of exceeding the threshold blood glucose levels, glycosuria, polydipsia and polyuria
occur.  Non-typical  symptoms  of  type  2  diabetes  include  fatigue  and reduced  mental  and
physical performance. This type of diabetes occurs primarily in people over 30 years of age,
and is most often accompanied by obesity and hypertension. The incidence of type 2 diabetes
is 90-95% compared to type 1 diabetes and increases with age. In Poland, about 1.6 million
people suffer from this  disease.  The basic method of treatment is to adjust  the right diet,
exercise or use of hypoglycemic agents [2, 6].
In addition to type 1 and type 2 diabetes, other types of diabetes are also distinguished,
including gestational type diabetes, type MODY and type LADA [1].
Laboratory tests to diagnose diabetes
        Hyperglycemia  occurs  naturally  in  all  types  of  diabetes,  regardless  of  their
etiopathogenesis  and  clinical  course.  Determination  of  blood  glucose  is  the  basic  and
indispensable laboratory test  used in the diagnosis of diabetes,  as well  as within the self-
control of patients. Due to the increasing prevalence of diabetes and the need to prevent and
monitor  the  disease,  the  determination  of  glycaemia  is  the  most  commonly  performed
biochemical examination in the diagnostic laboratory. Currently, there are two methods used
to determine glucose in blood in laboratories: 1. reference method - mass spectrometry with
isotope dilution (IDMS), 2. methods used in routine laboratory diagnostics,  hexokinase or
oxidase [7, 8].
        Preparing the patient for the study of fasting blood glucose should look like this: the test
should be performed in the morning after an overnight rest, and the patient must necessarily
be fasting and 24 hours before the test should not perform intense physical exercise, or change
their  diet.  The patient  should not  report  for  a period of  acute  infectious  or  inflammatory
disease and strictly give up alcoholic beverages that may affect glucose levels. If all of the
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above conditions have been met, we recognize diabetes when the blood glucose is ≥7mmol /
L [9].
        When  the  patient  has  an  abnormal  fasting  blood  glucose  (5.6-6.9  mmol  /  L)  to
diagnose  diabetes,  an  Oral  Glucose  Tolerance  Test  (OGTT)  should  be  performed.  Other
indications for the OGTT test are: 1. Features of the metabolic syndrome with normal fasting
glycemia,  2.  Glucoseuria  with  normal  fasting  glycemia,  3.  When  there  is  a  reasonable
suspicion  of  glucose  insufficiency  (in  elderly  people  without  overweight,  with  other  co-
existing risk factors for diabetes) . The patient should prepare for OGTT in the same way as
for testing fasting blood glucose. When all conditions are met, blood is drawn from the patient
(in the morning, after an overnight rest). The patient is then given 75 g of anhydrous glucose
dissolved in 200-300ml of water and must be consumed within 5 minutes. After drinking the
solution, the patient can not do any physical exertion for 2 hours, ideally he should remain at
rest. After 2 hours, the blood should be collected again. We recognize diabetes when after 2
hours in the OGTT test the blood glucose level is> 200mg / dl (11.1mmol / l) [1, 10].
           Diabetes can’t be diagnosed by glucometeres. They are used to monitor the level of
glucose in the blood that can be done at home. If two patient tests for the diagnosis of diabetes
gave conflicting results, confirm the test, the result of which exceeds the diagnostic point. In
risk groups, screening for diabetes is necessary because more than half of the patients do not
have symptoms of hyperglycaemia [1, 8].
             A test for diabetes mellitus should be done once every 3 years for every person over
45 years of age.  In addition,  regardless of age,  this  test  should be performed annually in
people who have risk groups: 1. People who are overweight or obese, 2. If diabetes affects the
closest family,  3. People who are not physically active,  4. People who had a pre-diabetic
status in a previous study, 5. In women with gestational diabetes, 6. People with hypertension,
7.  People  with  dyslipidemia,  8.  Women with  polycystic  ovary  syndrome,  9.  People  with
cardiovascular disease [1, 11].
       Another test in the diagnosis of diabetes is the determination of glycated hemoglobin
(HbA1c). It is used to monitor the treatment of diabetes, whose determination should be done
depending on the stability of the patient's disease. If the patient has a stable course of diabetes,
HbA1c should be done once a year,  whereas if  the patient  does not achieve the goals of
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treatment, HbA1c should be done at least once a quarter. Blood for this test is taken to an
EDTA tube or heparin. This study distinguishes the fact that the patient does not need to be
prepared for the test (does not have to be fasted). The HbA1c value reflects the average blood
glucose concentration in the period of about 3 months preceding the determination. It is a
retrospective  glycemic  index  and  a  risk  factor  for  the  development  of  chronic  diabetic
complications.  Determination of HbA1c should be performed in all  diabetic  patients.  The
result> 6.5% suggests diabetes [8, 9].
        The next parameter used in the diagnosis of diabetes is the determination of fructosamine
concentration.  In diabetic  patients,  the elevated fructosamine concentration correlates with
elevated  glucose  and  is  directly  proportional  to  the  concentration  of  blood  proteins.
Fructosamine reflects daily average glycemia over the last 2 weeks (albumin survival period)
prior to the test to control the effectiveness of diabetes treatment during this time. Due to large
fluctuations in the results (the impact of non-abortion factors, diet, albumin loss, liver disease)
is not as popular in diagnostics as HbA1c, but due to the short half-life is useful in monitoring
diabetes in pregnant and in closed care [8].
Clinical changes in a person with diabetes
1. Visual impairment 
          In the course of diabetes, there are changes in capillaries that have a basal membrane.
Increased blood sugar levels damage the blood vessels (capillaries) in the retina. Changes in
photosensitive  tissue,  or  retina,  caused  by  functional  and  specific  microangiopathy
complications for diabetes are called diabetic retinopathy. This clinical syndrome according to
WHO data in the diabetic population ranges from 20-60%. Of the 2 million people in the
Polish  population  suffering  from  diabetes,  up  to  600,000  people  suffer  from  diabetic
retinopathy [12, 13].
            Eye complications due to diabetes may also be extravascular changes occurring in the
eye organs, such as: cataract, glaucoma, inflammation or atrophy of the optic nerve, paralysis
of other nerves of the eyeball. In the initial stage of diabetes in the examination of the eye
organ, the oculomotor  nerve palsy innervating the eyeballs  is  rarely detected.  In the later
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period, symptoms that appear in vision disorders and even loss of sight are often intensified
[12, 14, 15, 16, 17].
           In patients with diabetes, two types of cataracts may occur: metabolic (diabetic) and
senile which is more common and usually among geriatric patients with type 2 diabetes. The
prolonged  exposure  to  hyperglycemia  undoubtedly  contributes  to  the  development  and
maturation of cataracts, which is confirmed by epidemiological studies indicating a greater
percentage of patients with cataracts among people with diabetes mellitus from people in the
same age group with normal blood sugar levels [12, 14, 16, 17].
          There are two types of changes in the eye organ of the nature of retinopathy. Non-
threatening  loss  of  vision   is  retinopathy  non-proliferative  in  which  the  formation  of
microaneurysms and venous congestion (angiopatia diabetica retinae) or minor patches in the
eye bottom resulting from retinal ischemia (retinopathy diabetica angiogens) is characteristic.
Vascular  lesions  that  lead  to  retinal  degeneration  and  marked  deterioration  of  vision  are
termed proliferative retinopathy. New blood vessels are formed that under the influence of
increased pressure in the capillaries burst and cause blood loss to the retina resulting in loss of
vision. Only retinal angiopathy is specific for those with diabetes. Other sets of symptoms in
the course of retinopathy also occur in other diseases [12, 17].
          The course and development of retinopathy depends on: the type of diabetes, the
duration of the disease and the degree of carbohydrate disorder. More often, retinal disease
affects  people  diagnosed  with  type  1  diabetes.  Pregnancy  affects  the  clinical  picture  of
retinopathy. More frequent widening of the retina veins is observed which is dependent on the
level  of  progesterone  and  estrogens.  In  the  course  of  proliferative  retinopathy,  retinal
hemorrhages occur more frequently,  which poses a threat to the organ of vision.  Diabetic
nephropathy, autonomic neuropathy, liver parenchymal disease and hypertension also have an
impact  on  the  progression  of  diabetic  retinopathy.  Elevated  intraocular  pressure  and  the
presence of other eye defects increase the progression of the disease [12, 13, 15, 16].
          Retinopathy rate is quite high, therefore it requires early diagnosis of the disease and
the use of appropriate treatment. Due to the possibility of vision loss good diabetes control
and frequent follow-up ophthalmologic examinations are necessary. Onset and progression of
non-proliferative retinopathy depend primarily on hyperglycaemia and can be significantly
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delayed through intensive insulin therapy. However, in the course of diagnosed proliferative
retinopathy, laser photocoagulation is used. Using this treatment in a timely manner reduces
the risk of blindness by half [13, 16, 17].
2. Cardiovascular disorders
        Cardiovascular disorders are a frequent cause of death in diabetics. In patients the 
incidence of cardiovascular events is higher than in healthy people. Inappropriately treated 
diabetes is the cause of macroangiopathic complications (damage to large vessels) and 
microangiopathic (small vessel damage) [18, 19].
Microangiopathic changes in diabetics result from long-term exposure of tissues to
hyperglycaemia. These changes occur as a result of summation of many factors - endothelium
damage, oxidative stress. As a consequence, we observe disturbed blood flow, deposition of
protein deposits outside the vessels - this leads to changes in tissues and insulin-dependent
organs (eg kidneys) [20].
In the case of macrovascular complications, atherosclerosis plays an important role.
The initial step of progression of atherosclerosis is the adhesion of monocytes to endothelial
cells, their subsequent migration to the intimal membrane, where monocytes are transformed
into macrophages. Foam cells are formed. As a result of subsequent changes in the vessel,
atherosclerotic plaque is formed. In a person with type 2 diabetes, the process of thickening
the walls of the vessel is faster. Hyperglycemia in these patients also leads to increased LDL
cholesterol, triglycerides, and reduced HDL cholesterol. In patients with type 1 diabetes, there
is also a greater risk of atherosclerosis through elevated blood sugar [18, 19]
Atherosclerosis in diabetics (also in cerebral arteries) increases the risk of stroke (2-3
times more often than in healthy people). Another consequence of atherosclerosis is impaired
collateral circulation, which adversely affects the blood supply to the lower limbs [21].
Insulin resistance and hyperinsulinaemia play a significant role in the pathogenesis of
type 2 diabetes. The absorption of sodium in the kidneys, thickening of the vessel wall and the
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retention of sodium and calcium in the vessel occurs. All this, together with stimulation of the
sympathetic system, leads to increased blood pressure [21].
It is estimated that the risk of cardiovascular death in diabetic patients is almost 3
times more frequent compared to healthy people. Appropriate treatment and constant patient
control are the key to reducing the cardiovascular risk associated with diabete [18, 21].
3. Disorders in the functioning of the kidneys
Nearly  30% of  patients  with  type  2  diabetes  develop  diabetic  kidney  disease.  In
Poland, as in many other countries, this complication of diabetes is one of the most common
reasons for the use of renal replacement therapy. Diabetic kidney disease is transformed into a
chronic kidney disease. This, along with diabetes, is one of the risk factors for the emergence
of cardiovascular complications. Both of these diseases also increase the risk of death. Due to
the prevalence and impact on the further life of patients, diabetic kidney disease is therefore a
very important problem [22, 23].
A  characteristic  feature  of  kidney  disease  is  their  abnormal  functioning  and/or
structural  changes  occurring  in  them  -  tissue  fibrosis,  caused  by  inflammation  and
haemodynamic  effects.  Genetic  factors  are  also  important.  All  this  ultimately  leads  to
irreparable damage to the organ. The fibrosis of the glomerulus and tubules very often leads
to chronic kidney disease. However, progressive chronic kidney disease leads to end-stage
renal failure requiring dialysis or renal transplantation to save lives [24].
Inflammation plays an important role in the pathomechanism of developing diabetic
kidney  disease.  It  can  be  activated  by  hyperglycemia,  the  renin-angiotensin  system  and
oxidative  stress.  Obesity  appearing  in  diabetics  is  also  important.  The  negative  effect  is
caused  by  the  increased  production  of  chemokine,  kidney  infiltration  by  monocytes  and
lymphocytes, as well as the production of pro-inflammatory cytokine and reactive oxygen.
The activity of inflammatory cells enhances the inflammatory response, cell damage and the
development of fibrosis in the organ. [25, 26].
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The  first  symptoms  of  changes  that  occur  in  the  kidneys’s  diabetic  patients  is
glomerular hyperfiltration occurring in the early stages of diabetes in the majority of people.
The glomerular permeability deficiency causes an increased amount of protein in the urine.
Already at the moment of diagnosis (diabetes) 1/3 of people have microalbuminuria - the first
biochemical  determinant  of diabetic  kidney disease.  Microalbuminuria  is  transformed into
macroalmbuminuria in nearly 3% of patients within one year [22, 26].
All diabetic patients should have a test for detection of diabetic kidney disease at least
once  a  year.  The  screening  tests  include:  urinalysis  and  GFR estimation.  In  the  case  of
persistent  albuminuria  or  the  appearance  of  protein  in  the  urine  and  co-existing  diabetic
retinopathy, diabetic nephropathy is diagnosed. Exclude other kidney diseases that could be
the cause of similar symptoms is necessary before making a diagnosis.
The basic therapeutic actions in the case of chronic kidney disease and slowing down
its  progression  is  glycemic  control.  The  latest  guidelines  emphasize  the  importance  of
maintaining the target percentage of glycosylated hemoglobin below 7%. With albuminuria it
is also important to maintain a pressure below 130/80 mm Hg. The drugs of choice in this
case  should  be  angiotensin  converting  enzyme  inhibitors  and  angiotensin  II  receptor
antagonists. Lipid disorders should also be under control. In the metabolism of many drugs
used  to  treat  diabetes,  the  kidneys  play  an  important  role.  Therefore,  it  is  important  to
properly  use  and  modify  medicaments  having  regard  to  the  presence  of  both  diseases  -
diabetes and diabetic nephropathy [22, 23].
Difficulties in contacting a patient with diabetes
Nervous system disorder is one of the most discussed topic in diabetes, but cognitive
disorders are an equally important aspect. Many studies indicate that cognitive impairment is
much more common in diabetic patients than in healthy people of the same age. This aspect is
extremely important because problems in the cognitive sphere significantly impede contact
between the doctor and the patient. Patients often do not understand treatment instructions
Niven by the doctor, and cannot use them. This limits their independence by the necessity of
third parties during their daily activities [27, 28].
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        According to psychologists, cognitive functions are mental activities that are used to
obtain  information  about  yourselves,  analyze  the  situation,  formulate  conclusions,  make
decisions  and  act.  Among  them  are:  perception,  attention,  memory,  learning,  thought
processes, executive functions, and language processes [29].
        Type  I  diabetes  weakens  cognitive  skills,  but  these  changes  are  short-lived  and
reversible. Type II diabetes has much greater difficulties in this matter. Patients suffer from
verbal and spatial memory impairment, the efficiency of attention processes, verbal fluency,
functions related to the frontal  lobe (mating functions),  psychomotor performance and are
associated with an increased risk of intellectual disorders [29].
In addition, diabetes doubles the risk of vascular dementia and dementia that develops
as a result of Alzheimer's disease. Tali Cukierman has even suggested placing a reduction in
cognitive performance in the group of chronic diabetic complications [28].
Aging processes take place much faster in patients with diabetes than in healthy peers.
Both  the  disease  and  the  physiological  aging  of  the  organism  significantly  affect  the
deterioration of cognitive functions or even lead to dementia [27].
In  case  of  any problems  with  communication,  the  treatment  team and the  speech
therapist need to be co-operated. Speech therapist role is to support the patient in improving
communication skills and implementing the doctor's recommendations. In addition, correct
communication significantly affects the quality of life of the patient and his / her mental state,
which may favorably affect the success of the whole treatment process [30].
Discussion 
An  elderly  person  with  diabetes  is  at  risk  of  developing  many  complications
associated with changes in the body, the listing and description of which significantly exceeds
the  scope  of  a  single  scientific  publication.  Considering  the  most  frequent  changes  and
considered the most important from the point of view of clinical practice, special attention
should be paid to the high risk of amputation of the lower limb, due to the high mortality
associated with it. Given the great importance of this issue for elderly patients with diabetes,
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Carmona et al. conducted a 10-year observation of people from the Geneva area (Switzerland)
for the occurrence, etiology and prognosis of lower limb amputation. According to the results
of their observation, the risk of amputation of the said limb increases by a factor of 10 in
elderly people who have diabetes. The forecasts turned out to be pessimistic, because as many
as  47% of  the  respondents  died  after  amputation.  This  demonstrates  the  need for  further
research into the management of patients after lower limb removal and the introduction of
specialized care methods,  consisting of rehabilitation,  pharmacotherapy,  and psychological
care to reduce mortality [31, 32].
The results of the article describe the impact of diabetes on cardiovascular changes.
These changes can often be recognized already on the basis of the clinical picture, which is of
great importance in practice due to the high speed of diagnosis at virtually zero financial
input.  An  example  is  the  possibility  of  diagnosing  asymptomatic  coronary  artery  disease
based on erectile dysfunction in older men with diabetes. Research carried out in Italy by
Gazzaruso  et  al.  confirms  the  importance  of  erectile  dysfunction  as  a  predictor  in  the
aforementioned disease, however, indicating that its usefulness decreases in people over 66
and should be used in younger patients. Because of the great importance in clinical practice,
activities should be carried out to detect and describe subsequent predictors in other diseases
[33].
The changes in the kidneys in people with diabetes described in the article are not the only
urinary  tract  disorders.  The  effect  of  diabetes  on  the  increased  development  of  urinary
incontinence in the elderly is also known and significant in clinical practice. However, the
exact  mechanism  by  which  this  phenomenon  occurs  remains  unsolved.  To  increase
knowledge about this issue, 322 patients with diabetes over 60 years of age, treated at the
National Geriatric Hospital in Hanoi (Vietnam), have been examined. The results of the study
include advanced age, long duration of diabetes, high levels of FPG and HbA1c, taking a
large amount of drugs, and the presence of cognitive impairment as factors that increase the
development of urinary incontinence in people with diabetes. The multitude of factors that
may increase the risk of the disorder in question suggests the need for further research on this
topic in the future [34].
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Conclusions
Diabetes  is  a  metabolic  disease  with  hyperglycaemia  due  to  various  causes.  This
disease often affects older people. Due to its increasing occurrence, rapid diagnostics and the
introduction of patient-specific treatment play a major role. Blood glucose is determined using
mass  spectrometry  with  isotope  dilution  (IDMS)  and  hexokinase  or  oxidase.  Diabetes  is
diagnosed when blood glucose is ≥7mmol / L. Diabetes cannot be diagnosed with a meter. An
important  test  in  the  diagnosis  of  diabetes  is  the  determination  of  glycated  hemoglobin
(HbA1c)  and  the  concentration  of  fructosamine.  It  is  important  to  remember  about  eye
damage  in  the  course  of  diabetes,  especially  in  seniors.  The  risk  of  developing  diabetic
retinopathy  is  increasing,  which  affects  20%  to  60%  of  patients.  Metabolic  and  senile
cataracts, glaucoma, optic neuritis or atrophy are further problems affecting senior citizens
with diabetes. Proliferative retinopathy is a threat to blindness. Its development is affected by
the type of diabetes,  the duration of the disease and the degree of carbohydrate disorders.
Diabetic nephropathy, autonomic neuropathy, liver parenchyma disease and hypertension as
well as elevated intraocular pressure and the presence of other eye defects are also important
factors.  Cardiovascular  disorders  are  a  common  cause  of  death  in  diabetics.  Prolonged
exposure of tissues to hyperglycemia results in impaired blood flow and protein deposition
outside the vessels. This type of patient is also at  risk for atherosclerosis.  Atherosclerosis
increases the risk of stroke and affects  the blood supply to  the lower extremities.  Insulin
resistance and hyperinsulinemia, on the other hand, play an important role in the pathogenesis
of type 2 diabetes. Cardiovascular diseases significantly increase the risk of death in patients
with diabetes compared to a healthy person. Almost half of the patients suffer from kidney
disease, which results in the use of renal replacement therapy. Diabetic kidney disease and
cardiovascular  disease  are  the  most  common  complications  of  diabetes.  Kidney  damage
results from inflammatory processes and vascular changes. Glomerular filtration is reduced,
which increases the amount of protein in the urine. Everyone with diabetes should be screened
for diabetic kidney disease once a year. During diabetes, the nervous system and cognitive
functions  are  damaged.  In  most  cases  these  are  reversible  changes.  There  are  memory
disorders,  problems  with  concentration,  psychomotor  and  intellectual  skills.  The  risk  of
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